EGF and pancreatic adenocarcinoma: In contrast, EGF exhibited significant differential expression in a more limited subset of cancers, specifically esophageal carcinoma, glioblastoma multiforme, liver hepatocellular carcinoma, lung adenocarcinoma (LUAD), lung squamous cell carcinoma, and pancreatic adenocarcinoma (Figure 1b).